This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okumura, K. Articles by Sasazuki, T. Search for Related Content PubMed PubMed Citation Articles by Okumura, K. Articles by Sasazuki, T.

Activated Ki-Ras Suppresses 12-O-Tetradecanoylphorbol-13-acetate-induced Activation of the c-Jun NH₂-Terminal Kinase Pathway in Human Colon Cancer Cells¹

Department of Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan

Although the frequency of activated Ki-ras genes is high in human colorectal tumors, much less is known of activated Ki-ras-mediated signaling pathways. Using gene targeting, we examined HCT116 cells that contain the Gly-13Asp mutation of Ki-ras and activated Ki-ras-disrupted clones derived from HCT116. 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced immediate early genes, such as c-Jun, c-Fos, and Egr-1 in activated Ki-ras-disrupted clones, whereas c-Jun induction was rare in HCT116. TPA induced both phosphorylation of stress-activated protein kinase kinase 1 (SEK1) and c-Jun NH₂-terminal kinase (JNK) in the activated Ki-ras-disrupted clones but not in HCT116. On the other hand, TPA-induced mitogen-activated protein kinase kinase 1/2 (MEK1/2)-extracellular signal-regulated kinase (ERK) activation was equally induced between HCT116 and the Ki-ras-disrupted clones. Furthermore, TPA-induced SEK1-JNK activation was observed in a DLD-1-derived activated Ki-ras-disrupted clone but not in DLD-1. The TPA-induced SEK1-JNK activation in these disrupted clones was completely inhibited by the protein kinase C (PKC) inhibitor, GF109203X (1 µM), but not by another PKC inhibitor, H7 (50 µM), whereas TPA-induced MEK1/2-ERK activation was partially and completely inhibited by GF109203X (1 µM) and H7 (50 µM), respectively. A phosphoinositol 3-kinase inhibitor, LY294002, did not inhibit the TPA-induced SEK1-JNK activation. Taken together, these results suggest that activated Ki-Ras-mediated signals are involved in the SEK1-JNK pathway through a PKC isotype that is distinct from that involved in MEK1/2-ERK activation in human colon cancer cells and independent of phosphoinositol 3-kinase activation, and the imbalance between ERK and JNK activity caused by activated Ki-Ras may play critical roles in human colorectal tumorigenesis.

This article has been cited by other articles:

				Y. Sun and F. A. Sinicrope Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells Mol. Cancer Ther., January 1, 2005; 4(1): 51 - 59. [Abstract] [Full Text] [PDF]

				X. Qi, J. Tang, R. Pramanik, R. M. Schultz, S. Shirasawa, T. Sasazuki, J. Han, and G. Chen p38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells through Regulation of Vitamin D Receptor J. Biol. Chem., May 21, 2004; 279(21): 22138 - 22144. [Abstract] [Full Text] [PDF]

				J. Zhang, V. Svehlikova, Y. Bao, A.F. Howie, G. J. Beckett, and G. Williamson Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation Carcinogenesis, March 1, 2003; 24(3): 497 - 503. [Abstract] [Full Text] [PDF]

				T. Tsunoda, J. Inokuchi, I. Baba, K. Okumura, S. Naito, T. Sasazuki, and S. Shirasawa A Novel Mechanism of Nuclear Factor {kappa}B Activation through the Binding between Inhibitor of Nuclear Factor-{kappa}B{alpha} and the Processed NH2-terminal Region of Mig-6 Cancer Res., October 15, 2002; 62(20): 5668 - 5671. [Abstract] [Full Text] [PDF]

				P. Maher How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death J. Neurosci., May 1, 2001; 21(9): 2929 - 2938. [Abstract] [Full Text] [PDF]

				I. Baba, S. Shirasawa, R. Iwamoto, K. Okumura, T. Tsunoda, M. Nishioka, K. Fukuyama, K. Yamamoto, E. Mekada, and T. Sasazuki Involvement of Deregulated Epiregulin Expression in Tumorigenesis in Vivo through Activated Ki-Ras Signaling Pathway in Human Colon Cancer Cells Cancer Res., December 1, 2000; 60(24): 6886 - 6889. [Abstract] [Full Text]

				J. A. Recio, J. G. Páez, B. Maskeri, M. Loveland, J. A. Velasco, and V. Notario Both Normal and Transforming PCPH Proteins Have Guanosine Diphosphatase Activity But Only the Oncoprotein Cooperates with Ras in Activating Extracellular Signal-regulated Kinase ERK1 Cancer Res., March 1, 2000; 60(6): 1720 - 1728. [Abstract] [Full Text]

				A. Rebollo and C. Martinez-A Ras Proteins: Recent Advances and New Functions Blood, November 1, 1999; 94(9): 2971 - 2980. [Full Text] [PDF]